GLP-1 Class
Semaglutide
COA VERIFIEDPOPULARNEW

Semaglutide

C₁₈₇H₂₉₁N₄₅O₅₉

GLP-1 Class
HPLC PURITY98.5%

GLP-1 receptor agonist extensively studied for metabolic research and glucose homeostasis.

Molecular Weight
4113.58 g/mol
Appearance
White to off-white lyophilized powder
Storage
Store at -20°C. Protect from light.

Select Size

Quantity

1
$79.99

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for the treatment of type 2 diabetes. It has been extensively studied for its effects on glucose homeostasis, appetite regulation, and metabolic function. Research demonstrates potent GLP-1 receptor binding and resistance to DPP-4 degradation due to structural modifications. This compound is a critical research tool in metabolic science and weight management studies.

Related Compounds

Retatrutide
COA VERIFIEDNEW

GLP-1 Class

Retatrutide

C₂₂₇H₃₄₈N₄₈O₆₈S

Novel triple agonist (GIP/GLP-1/glucagon) peptide under investigation for metabolic research.

HPLC PURITY98.3%
From $89.99
Tirzepatide
COA VERIFIEDPOPULAR

GLP-1 Class

Tirzepatide

C₂₂₅H₃₄₈N₄₈O₆₈

Dual GIP/GLP-1 receptor agonist studied for glucose metabolism and body composition research.

HPLC PURITY98.6%
From $99.99

Research Use Only — Legal Disclaimer

All products sold by Halo Peptides are strictly intended for in-vitro research, laboratory use, and scientific investigation only. They are not intended for human consumption, veterinary use, diagnostic purposes, or any therapeutic application. By browsing this website and purchasing any product, you acknowledge and agree that you are a qualified researcher and will use all compounds in compliance with applicable local, national, and international laws and regulations.